Skip to main content

Mono Bar

Subsite Title

Publications and Digital Products

Cart

Store Navigation

Share Buttons

Page title

Drug Abuse Warning Network: Findings from Drug-Related Emergency Department Visits, 2021

Main page content

Download only

An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (4) the identification of drugs new to DAWN’s Drug Reference Vocabulary.

Publication ID
PEP22-07-03-002
Publication Date
December 2022
Format

You May Also Be Interested In

Preliminary Findings from Drug-Related Emergency Department Visits, 2021: Results from the Drug Abuse Warning Network

An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3) the identification of drugs new to DAWN’s Drug Reference Vocabulary.

A Guide for Taking Care of Your Family Member After Treatment in the Emergency Department

This brochure was developed by and for family members whose loved one attempted suicide. It provides information about what to expect in the emergency room, and how to take care of yourself and your family member following the attempt. It also offers resources to help you move forward.

Use of Medication-Assisted Treatment in Emergency Departments

This guide examines emerging and best practices for initiating medication-assisted treatment in emergency departments. It also reviews the existing literature and science of the topic, identifies gaps in knowledge, and discusses challenges of implementation.

Treating Concurrent Substance Use Among Adults

This guide intends to educate clinicians and other stakeholders about the harms of using more than one substance and consideration for addressing concurrent substance use (CSU) and concurrent substance use disorders (CSUD).

Treatment for Youth and Young Adults with Mood Disorders and other Serious Emotional Disturbances and Co-occurring Substance Use

This guide reviews interventions on treating substance misuse and substance use disorders (SUD) in youth with serious emotional disturbances (SED), distills the research into recommendations for practice, and provides examples of the ways that these recommendations can be implemented.

First-Episode Psychosis and Co-Occurring Substance Use Disorders

This guide supports health care providers, systems, and communities to address first-episode psychosis and co-occurring substance use disorders. It describes relevant research, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers resources.